Press & events

What's happening?

Stay updated on our latest news and events.

Displaying 21 - 30 of 379

Press

Recipharm’s Board of Directors decides to withdraw dividend proposal

2020.04.08 Read more

Press

Recipharm’s proprietary molecule Erdosteine to be tested as part of COVID-19 treatment

2020.04.08 Read more

Press

Recipharm closes offer for Consort Medical

2020.04.03 Read more

Press

Recipharm supports FDA approval of Perrigo’s AB-rated generic product

2020.03.11 Read more

Press

Recipharm operations in Italy continue largely unaffected

2020.03.09 Read more

Press

Recipharm notes an increased demand for Chloroquine Phosphate

2020.03.06 Read more

Press

Recipharm completes delisting of Consort Medical

2020.03.06 Read more

Press

Recipharm names 2019 International Environmental Award winner

2020.02.24 Read more

Press

Recipharm commences squeeze-out of Consort Medical shares

2020.02.20 Read more

Press

Recipharm AB publishes report for the fourth quarter and full year 2019

2020.02.20 Read more